4-(2-(Diphenylphosphino)phenyl)-3,4-dihydro-2H-benzo[b][1,4]oxazine

Catalog No. :
ACWCGA985
CAS No. :
1350654-31-7
Molecular Formula :
C26H22NOP
Molecular Weight :
395.44

IUPAC Name:4-(2-(diphenylphosphaneyl)phenyl)-3,4-dihydro-2H-benzo[b][1,4]oxazine

4-(2-(Diphenylphosphino)phenyl)-3,4-dihydro-2H-benzo[b][1,4]oxazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$139.00Login to see priceInquiryInquiry
250mg95%$235.00Login to see priceInquiryInquiry
1g95%$639.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(2-(Diphenylphosphino)phenyl)-3,4-dihydro-2H-benzo[b][1,4]oxazine
IUPAC Name4-(2-(diphenylphosphaneyl)phenyl)-3,4-dihydro-2H-benzo[b][1,4]oxazine
Molecular FormulaC26H22NOP
Molecular Weight395.44
SMILESN1(C2=CC=CC=C2P(C3=CC=CC=C3)C4=CC=CC=C4)CCOC5=CC=CC=C15
InChI KeyHQWIEEJPLVTXDR-UHFFFAOYSA-N
Synonym4-(2-(Diphenylphosphino)phenyl)-3,4-dihydro-2H-benzo[b][1,4]oxazine
CAS No.1350654-31-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACWCGA985 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHATJ157 route compound structure diagram
    ACHATJ15762336-24-7 In Stock
  2. Plus
  3. ACRKLP219 route compound structure diagram
    ACRKLP2195735-53-5 In Stock
  4. Then
  5. ACWCGA985 route product structure diagram
    ACWCGA9851350654-31-7
Inquiry

2. ACWCGA985 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRKLP219 route compound structure diagram
    ACRKLP2195735-53-5 In Stock
  4. Then
  5. ACWCGA985 route product structure diagram
    ACWCGA9851350654-31-7
Inquiry

Comments (0)